Bill > HB05714

This bill requires pharmacists who are dispensing mifepristone (a medication commonly used for medical abortion) to provide patients with written information explaining that the drug's effects might potentially be reversible if the patient decides to continue the pregnancy and seeks intervention quickly. Mifepristone is typically used in combination with another medication to end an early pregnancy, and this bill aims to inform patients about the possibility of intervention if they change their mind after initially taking the first medication. The bill's stated purpose is to protect reproductive rights by ensuring patients are aware of potential options if they decide they want to continue their pregnancy after beginning the medication process. By mandating that pharmacists provide this written information, the legislation seeks to give patients additional information and potential alternatives at the time of medication dispensation.

Health and Social Services

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB05714&which_year=2025